Clinical efficacy of chloroquine derivatives in COVID-19 infection: comparative meta-analysis between the big data and the real world-Reference-Cited by-同舟云学术

Clinical efficacy of chloroquine derivatives in COVID-19 infection: comparative meta-analysis between the big data and the real world

Published:2020-11 Issue: Volume:38 Page:100709
ISSN:2052-2975
Container-title:New Microbes and New Infections
language:en
Short-container-title:New Microbes and New Infections

Author:

Million M.,Gautret P.,Colson P.,Roussel Y.,Dubourg G.,Chabriere E.,Honore S.,Rolain J.-M.,Fenollar F.,Fournier P.-E.,Lagier J.-C.,Parola P.,Brouqui P.,Raoult D.

Funder

ANR Investissements d’avenir

Méditerranée infection

Région Provence-Alpes-Côte d'Azur

Mediterranean Infection Foundation

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology

Reference38 articles.

1. Bouillabaisse or fish soup: the limitations of meta-analysis confronted to the inconsistency of fecal microbiota transplantation studies;Lagier;Clin Infect Dis,2020

2. From expert protocols to standardized management of infectious diseases;Lagier;Clin Infect Dis,2017

3. Relevance of medical big data analysis depends on clinical accuracy: the Q fever paradigm;Million;Clin Infect Dis,2019

4. Clinical features and complications of Coxiella burnetii infections from the French National Reference Center for Q fever;Melenotte;JAMA Netw Open,2018

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is meta-analysis the "top of the evidence pyramid" in cardiology?;Cardiovascular Therapy and Prevention;2024-02-24

2. Early Treatment with Hydroxychloroquine and Azithromycin: A ‘Real-World’ Monocentric Retrospective Cohort Study of 30,423 COVID-19 Patients;2023-04-04

3. Comprehensive evaluation of six interventions for hospitalized patients with COVID-19: A propensity score matching study;Saudi Pharmaceutical Journal;2023-04

4. Computational approaches for drug discovery against COVID-19;Omics approaches and technologies in COVID-19;2023

5. The failure of drug repurposing for COVID-19 as an effect of excessive hypothesis testing and weak mechanistic evidence;History and Philosophy of the Life Sciences;2022-10-18